Corrigendum: Muscle-Specific CRISPR/Cas9 Dystrophin Gene Editing Ameliorates Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy

Nature Communications - United Kingdom
doi 10.1038/ncomms16007